Skip to main content

Advertisement

Log in

Outcomes Following Treatment of Pelvic Exenteration for Rectal Cancer in a Tertiary Care Center

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Pelvic exenteration is potentially curative for operable locally advanced primary and locally recurrent rectal cancers. R0 resection is associated with higher survival. This procedure is associated with low mortality rates but high postoperative morbidity proportional to the extent of resection. This study was done to find out the survival outcome and morbidity associated with this procedure and to determine prognostic factors associated with postoperative outcomes. Seventy-three patients with rectal cancer underwent pelvic exenteration between January 2009 and December 2020. Sixty-six patients had locally advanced rectal cancer and 7 patients had recurrent cancer. All patients with primary tumors were evaluated with MRI pelvis and CT scan of the chest and abdomen while patients with recurrence were evaluated with a PET scan. The median follow-up duration was 39 months. The majority of patients were in the age group 40–69 years. Thirty patients were males and 43 were females. The 30-day postoperative major morbidity was reported in 28 patients (38.4%). The most common morbidity was wound dehiscence. The mean overall survival (OS) was 110.6 months (95% CI, 97.5–123.7) and mean disease free survival (DFS) was 85 months (95% CI, 71.0–100.4). R0 resection was associated with favorable overall survival. Tailored exenterations were associated with low morbidity. En bloc partial sacrectomy helped achieve R0 resection in patients who underwent the procedure. Extended resections yielded high R0 resection rates with favorable survival (65 months) but were associated with high morbidity. These procedures shall be best practiced in high-volume institutes of expertise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yang TX, Morris DL, Chua TC (2013) Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 56(4):519–531

    Article  PubMed  Google Scholar 

  2. Xin KY, Ng DWJ, Tan GHC, Teo MCC (2014) Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer. J Gastrointest Cancer 45(3):291–297

    Article  PubMed  Google Scholar 

  3. Collaborative PelvEx (2019) Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg 269(2):315–321

    Article  Google Scholar 

  4. Sasikumar A, Bhan C, Jenkins JT, Antoniou A, Murphy J (2017) Systematic review of pelvic exenteration with en bloc sacrectomy for recurrent rectal adenocarcinoma: R0 resection predicts disease-free survival. Dis Colon Rectum 60(3):346–352

    Article  PubMed  Google Scholar 

  5. Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259(2):315–322

    Article  PubMed  Google Scholar 

  6. Gezen C, Kement M, Altuntas YE, Okkabaz N, Seker M, Vural S et al (2012) Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol 10(1):39

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kumar NA, Sasi SP, Shinde RS, Verma K, Sugoor P, Desouza A, Engineer R, Saklani A (2020) Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer. JSLS 24(3):e2020.00026. https://doi.org/10.4293/JSLS.2020.00026

  8. Carballo L, Enríquez-Navascués JM, Saralegui Y, Placer C, Timoteo A, Borda N et al (2015) Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia. Cir Esp (Engl Ed) 93(3):174–180

    Article  Google Scholar 

  9. Barbaro B, Vitale R, Leccisotti L, Vecchio FM, Santoro L, Valentini V et al (2010) Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30(3):699–716

    Article  PubMed  Google Scholar 

  10. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 22(1):29–42. https://doi.org/10.1016/S1470-2045(20)30555-6

    Article  CAS  PubMed  Google Scholar 

  11. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196

    Article  PubMed  Google Scholar 

  12. Grimes WR, Stratton M (2022) Pelvic exenteration. StatPearls Publishing

    Google Scholar 

  13. Kim J (2012) Pelvic exenteration: surgical approaches. J Korean Soc Coloproctol. 28(6):286–93. https://doi.org/10.3393/jksc.2012.28.6.286

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lampe B, Luengas-Würzinger V, Weitz J, Roth S, Rawert F, Schuler E et al (2021) Opportunities and limitations of pelvic exenteration surgery. Cancers (Basel) 13(24):6162

    Article  PubMed  Google Scholar 

  15. Fahy MR, Hayes C, Kelly ME, Winter DC (2022) Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer. Eur J Surg Oncol 48(11):2284–2291

    Article  PubMed  Google Scholar 

  16. Nielsen CKP, Sørensen MM, Christensen HK, Funder JA (2022) Complications and survival after total pelvic exenteration. Eur J Surg Oncol 48(6):1362–7

    Article  Google Scholar 

  17. Collaborative The PelvEx, Kelly ME, Glynn R, Aalbers AGJ, Abraham-Nordling M, Alberda W et al (2018) Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer: factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg 105(6):650–7

    Article  Google Scholar 

  18. Bogner A, Fritzmann J, Müssle B, Huber J, Dobroschke J, Bork U et al (2021) Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome. Int J Colorectal Dis 36(8):1701–1710

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nizamudheen M. Pareekutty.

Ethics declarations

Ethics Approval

Approved.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

S, V., Pareekutty, N.M. & Balasubramanian, S. Outcomes Following Treatment of Pelvic Exenteration for Rectal Cancer in a Tertiary Care Center. Indian J Surg Oncol 15, 420–427 (2024). https://doi.org/10.1007/s13193-024-01918-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-024-01918-w

Keywords

Navigation